​

neoX is a biotech company that combines artificial intelligence (AI) with biophysics for drug research and development. neoX focuses on the research and development of macromolecular drugs and multispecific drugs, especially in the field of immuno-oncology. It has developed a sophisticated platform for early discovery of therapeutics by characterizing protein-protein interactions (PPI). neoX has established cooperation with biomedical companies globally to accelerate drug R&D pipelines. 

​

​

星亢原是一家将人工智能（AI）与生物物理相结合，进行药物研发的生物高科技公司。星亢原专注大分子药物和多特异性分子药物研发，尤其是在肿瘤免疫治疗领域。 针对治疗药物的早期发现，星亢原通过表征蛋白质-蛋白质相互作用（PPI）开发了一个强大的研发平台。星亢原已经与国内外生物医药公司建立合作，布局药物研发管线。

​

neoX的公司文化是在自由、平等的工作环境中，相互学习，激发每一个人的潜能，实现自我价值，并携手完成共同的使命。

​

​